Qualidade de vida e função sexual de mulheres submetidas ao tratamento para o câncer do colo do útero
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora
DOI
Abstract
The high curability of cervical cancer (CC), when detected early, coupled with the
latest scientific advances in the treatment of disease, has contributed to increased
survival of patients. However, its treatment can lead to significant late adverse effects
such as sexual dysfunctions that compromise significantly the quality of life (QoL).
Thus, it becomes essential to investigate the QoL and sexual function of survivors at
the CC in order to verify, holistically, the real needs of these patients and guide the
actions of inter and multidisciplinary teams. And with that, provide a convenient and
humanizing care that meets all these requirements, it is not enough to increase
survival, it is necessary to have this quality survival. Within this context, the main
objective of this research was to assess quality of life and sexual function in women
submitted to treatment for cervical cancer, and compare with a control group of
women without a history of cancer. It is, analytical, observational, epidemiological
study of case-control sample with a total of 74 women divided into cancer group -
CaG (women submitted to treatment for cancer of the cervix for at least three months
- n = 37) and population-based control group - CoG (women without a history of
cancer - n = 37). Three questionnaires were applied: a general characterization of the
sample, a survey for evaluating the quality of life, developed by the World Health
Organization (WHOQOL-BREF), and an instrument for assessment of sexual
function (Female Sexual Function Index - FSFI). The control group had a higher
frequency of women living with a partner (CoG = 73%; CaG = 51.4%, p = 0.05) and
women who considered the relationship even as good or very good (CoG = 93 1%;
CaG = 63.2%, p = 0.02). The following variables related to potential adverse effects
of treatment were more frequent in the cancer group: menopause (CoG = 59.5%;
CaG = 100%, p ˂ 0.01), bleeding during or after intercourse (CoG = 0; CaG = 36.8%,
p ˂ 0.01) increase in the frequency (CoG = 0; CaG = 37.8%, p ˂ 0.01), urgency (CoG
= 16.2%; CaG = 37.8 %, p = 0.03), incontinence (CoG = 10.8%; CaG = 35.1%, p =
0.02) and urinary retention (CoG = 2.7%; CaG = 21.6%, p = 0.02), diarrhea (CoG = 0;
CaG = 43.2%, p ˂ 0.01), urgency (CoG = 0; CaG = 37.8%, p ˂ 0.01) and fecal
incontinence (CoG = 0; CaG = 21.6%, p ˂ 0.01), pain (CoG = 0; CaG = 21.6%, p ˂
0.01) and anal mucus (CoG = 0; CaG = 18.9% p = 0.01), rectal bleeding (CoG = 0;
CaG = 24.3%, p ˂ 0.01) and lower limb lymphedema (CoG = 0; CaG = 35.1%, p ˂
0.01). Moreover, the cancer group had worse results as related to sexual function
variables: 64.9% reported narrow or too short vagina most were not sexually active
(59.5%) and women who had sexual intercourse, 80 % dysfunctional. Statistically
significant difference between groups in the fields "Physical" and "Social Relations"
WHOQOL-BREF was found, while the average of these areas was higher in the
control group. The averages of cancer group were statistically lower than the control
group in all domains of FSFI, and total score of the instrument. Considering the
results, it is concluded that there is negative impact of treatment for CC in QoL and
sexual function of survivors. From this, one can contribute to giving greater visibility
to these issues in clinical practice, seeking to guide interventions in order to attend all
the needs of these patients, contributing to a better quality of life in survivors.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Rights and licensing
Acesso Aberto
